Acadia Pharmaceuticals Inc (ACAD)

Income Tax Expense

$14.97M

Quarterly · Period ending: · USD

ACAD logo

ACAD Income Tax Expense

Latest reported$14.97M
ACAD Quarterly Income Tax ($158.10K → $14.97M)
High-resolution chart · PNG

ACAD income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Income Tax Expense — Quarterly (USD)
Period endingIncome Tax Expense (USD)
14,973,000
344,000
-247,249,000
-27,184,000
13,545,000
8,792,000
17,343,000
6,041,000
3,793,000
4,447,000
-6,094,000
13,033,000
5,229,000
-1,918,000
835,000
768,000
443,000
485,000
189,000
-332,000
473,000
21,000
417,000
-199,000
393,000
0
400,000
-264,000
365,000
375,000
14,000
376,000
219,000
647,000
-31,000
0
398,000
85,000
1,341,000
0
0
0
330,000
0
0
-122,000
-62,000
0
0
0
0
-16,000
-12,000
-12,000
-14,039,000
0
0
0
-17,465,000
0
0
0
-14,002,000
0
0
0
-36,457,000
0
0
0
-33,901,000
0
0
0
-39,352,000
1,000
0
0
-32,597,000
-1,276,000
-997,000
-633,000
-23,932,200
-506,400
456,343,200
210,789,000
-18,582,200
107,892,000
-1,198,800
49,200
3,523,150
3,523,150
72,700
158,100
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.